Yiannis Mouratidis, Contributor

New machine learning algorithms drive liquid biopsy tests to new levels of efficacy

The growing ecosystem of companies involved in the leverage of AI technologies on health care and drug development needs a new evaluation scheme, more complicated than the typical evaluation schemes for startups in other sectors

You feel younger than you are and maybe you are. Our birth date may not match our body’s age

From a different point of view, the verdict against Monsanto’s Roundup is a sad reminder that agricultural production cannot survive without chemicals

RNA analysis promises less fails in Anti-tumor necrosis factor treatment

The scientists at the PHI, Hawaii are using advanced technologies to improve the diagnosis and treatment of cancer. Their research is unique because they examine how cancer affects people with different ethnic, cultural and environmental characteristics.

With almost 40% of its research and development budget targeting blue sky research, IBM tries to keep its place in the fierce competition for the next computing era

People with chronic conditions need extra care even for the simplest tasks, like going to the pharmacy or taking their medicines

Τhe Arctoris cloud frees cancer researchers from a big burden of everyday work and offers more quality time for data interpretation

RTsafe aims to improve the results of radiotherapy in brain cancers, using a pseudo head for testing